MedTrace Logo

A Comparison of Etomidate and Ketamine for Anesthesia Induction in Coronary Artery Bypass Graft Surgery

NCT01386229 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2011-07-01

No results posted yet for this study

Summary

The aim of this study is to determine whether ketamine is an acceptable alternative to etomidate for anesthesia induction in coronary artery bypass graft surgery in terms of hemodynamic stability and also to compare these agents regarding their effect on adrenal gland steroid synthesis in these patients.

Conditions

  • Coronary Artery Bypass Surgery

Interventions

DRUG

Ketamine

During standard anesthesia induction with fentanyl and midazolam, ketamine 2 mg/kg IV will be administered

DRUG

Etomidate

During standard anesthesia induction with fentanyl and midazolam, etomidate 3 mg/kg IV will be administered

Sponsors & Collaborators

  • Baskent University

    lead OTHER

Principal Investigators

  • Özgür Kömürcü · Baskent University, Faculty of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2011-12-31
Completion
2012-03-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01386229 on ClinicalTrials.gov